TABLE 1

Saccadic Latency Before and After Administration of Placebo or 5 mg of Olopatadine

		After administration
Visit	Before administration	30 min	60 min	180 min	Increase^*
Baseline (placebo)	0.24 ± 0.16	0.27 ± 0.14	0.29 ± 0.12	0.33 ± 0.12	38% ± 12%
Acute scan (0 wk)	0.21 ± 0.08	0.23 ± 0.10	0.22 ± 0.18	0.30 ± 0.17	42% ± 17%
Interim (2 wk)	0.23 ± 0.10	0.25 ± 0.20	0.24 ± 0.12
Chronic scan (4 wk)	0.23 ± 0.11	0.25 ± 0.18	0.26 ± 0.14	0.30 ± 0.16	30% ± 14%

↵* Average percentage increase in maximum latency for each subject after drug administration.
Data are mean ± SD, in seconds (n = 14). No statistically significant difference was found between pre- and postadministration data at any visit.